Adaptimmune Therapeutics plc (MUN:473A)
Germany · Delayed Price · Currency is EUR 0.0160
0.00 (0.00%)
Last updated: Jun 22, 2026, 8:00 AM CET
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of €9.26 million as of June 23, 2026. Its market cap has decreased by -86.00% in one year.
Market Cap
9.26M
Enterprise Value
-1.11M
Revenue
5.05M
Ranking
n/a
PE Ratio
0.43
Stock Price
€0.02
Market Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 9.26M, a decrease of -99.14%. That is a compound annual growth rate of -34.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 9.26M | 57.84% |
| Dec 31, 2025 | 5.87M | -95.59% |
| Dec 31, 2024 | 133.14M | -18.29% |
| Dec 29, 2023 | 162.94M | -27.20% |
| Dec 30, 2022 | 223.81M | -56.55% |
| Dec 31, 2021 | 515.06M | -24.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Darwin AG | 95.40M |
| 2invest AG | 44.52M |
| Biomark Diagnostics | 33.01M |
| Vidac Pharma Holding | 25.71M |
| co.don AG | 414.21K |
| Paion AG | 385.22K |
| bioXXmed AG | 222.93K |